The RNA Component of Human Telomerase
The DOI matches its Crossref record; 44 of the 44 references it cites were found in a registry or an index.
Abstract
Eukaryotic chromosomes are capped with repetitive telomere sequences that protect the ends from damage and rearrangements. Telomere repeats are synthesized by telomerase, a ribonucleic acid (RNA)-protein complex. Here, the cloning of the RNA component of human telomerase, termed hTR, is described. The template region of hTR encompasses 11 nucleotides (5′-CUAACCCUAAC) complementary to the human telomere sequence (TTAGGG) n . Germline tissues and tumor cell lines expressed more hTR than normal somatic cells and tissues, which have no detectable telomerase activity. Human cell lines that expressed hTR mutated in the template region generated the predicted mutant telomerase activity. HeLa cells transfected with an antisense hTR lost telomeric DNA and began to die after 23 to 26 doublings. Thus, human telomerase is a critical enzyme for the long-term proliferation of immortal tumor cells.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Key components of telomerase are telomerase reverse transcriptase (TERT) (88) and telomerase RNA (89).”
From The Discovery of Reverse Transcriptase (2016) · cites this paper as [89]
In the citing paper
“expression of antisense RNA complementary to the human telomerase RNA component (hTR) caused decreased proliferation of HeLa cells after 23 to 26 doublings (24).”
From Inhibition of human telomerase in immortal human cells leads to progressive telomere shortening and cell death (1999) · cites this paper as [24]
In the citing paper
“The shortening of telomeres occurs with each cell division, ultimately causing cells to reach their Hayflick limit, whereby growth stops after approximately 60 times population doubling [2,3,4,5].”
From Cell Immortality: In Vitro Effective Techniques to Achieve and Investigate Its Applications and Challenges (2024) · cites this paper as [5]
In the citing paper
“When telomeres become too short and cannot function naturally, cellular senescence in the M1 phase (a cellular growth arrest, also called the M1 stage) occurs [5,6,7].”
From Cell Immortality: In Vitro Effective Techniques to Achieve and Investigate Its Applications and Challenges (2024) · cites this paper as [5]
In the citing paper
“In human cells, the enzyme comprises a high molecular weight complex with a template-containing RNA subunit (Feng et al., 1995) and protein components including the catalytic subunit human telomerase reverse transcriptase, hTERT (Harrington et al., 1997;Meyerson et al., 1997;Nakamura et al., 1997).”
From A highly selective telomerase inhibitor limiting human cancer cell proliferation (2001) · cites this paper as Feng et al., 1995
Citations
Cites
DNA sequencing with chain-terminating inhibitors
Sanger, F., Nicklen, S., & Coulson, A. R. (1977) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.74.12.5463 · Cited by 68,572
Specific Association of Human Telomerase Activity with Immortal Cells and Cancer
Kim, N. W., Piatyszek, M. A., Prowse, K. R., Harley, C. B., West, M. D., Ho, P. L. C., Coviello, G. M., Wright, W. E., Weinrich, S. L., & Shay, J. W. (1994) · Science · doi:10.1126/science.7605428 · Cited by 7,091
Self-citationTelomeres shorten during ageing of human fibroblasts
Harley, C. B., Futcher, A. B., & Greider, C. W. (1990) · Nature · doi:10.1038/345458a0 · Cited by 5,750
Self-citationTight control of gene expression in mammalian cells by tetracycline-responsive promoters.
Gossen, M., & Bujard, H. (1992) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.89.12.5547 · Cited by 4,943
Identification of a specific telomere terminal transferase activity in tetrahymena extracts
Greider, C. W., & Blackburn, E. H. (1985) · Cell · doi:10.1016/0092-8674(85)90170-9 · Cited by 3,400
Self-citationTelomere length predicts replicative capacity of human fibroblasts.
Allsopp, R. C., Vaziri, H., Patterson, C., Goldstein, S., Younglai, E. V., Futcher, A. B., Greider, C. W., & Harley, C. B. (1992) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.89.21.10114 · Cited by 2,200
Self-citationCounter, C. M., Avilion, A. A., LeFeuvre, C. E., Stewart, N. G., Greider, C. W., Harley, C. B., & Bacchetti, S. (1992) · The EMBO Journal · doi:10.1002/j.1460-2075.1992.tb05245.x · Cited by 2,096
Self-citationOlovnikov (1973) · doi:10.1016/0022-5193(73)90198-7 · Cited by 1,847
Telomere reduction in human colorectal carcinoma and with ageing
Hastie, N. D., Dempster, M., Dunlop, M. G., Thompson, A. M., Green, D. K., & Allshire, R. C. (1990) · Nature · doi:10.1038/346866a0 · Cited by 1,650
A telomeric sequence in the RNA of Tetrahymena telomerase required for telomere repeat synthesis
Greider, C. W., & Blackburn, E. H. (1989) · Nature · doi:10.1038/337331a0 · Cited by 1,643
Self-citation
Research works printed but not linked: 7
- AUTEXIER, C, FUNCTIONAL RECONSTITUTION OF WILD-TYPE AND MUTANT TETRAHYMENA TELOMERASE, GENES & DEVELOPMENT 8: 563 (1994). · DOI
- AVILION A.A. THESIS STATE U NEW Y (1995).
- Broccoli, D., Proceedings of the National Academy of Sciences of the United States of America 92: 9082 (1995).
- CHADENEAU, C, ONCOGENE 11: 841 (1995).
- Hernandez, N., Transcriptional Regulation: 281 (1992).
- Muller, H. J., Collecting Net 13: 181 (1938).
- WATSON, J. D., NATURE-NEW BIOLOGY 239: 197 (1972).
Cited by
Items 201–300 of 1,004
Cellular delivery of peptide nucleic acids and inhibition of human telomerase
Hamilton, S. E., Simmons, C. G., Kathiriya, I. S., & Corey, D. R. (1999) · Chemistry & Biology · doi:10.1016/s1074-5521(99)80046-5 · Cited by 170
Dragon, F., Pogačić, V., & Filipowicz, W. (2000) · Molecular and Cellular Biology · doi:10.1128/mcb.20.9.3037-3048.2000 · Cited by 166
White, L. K., Wright, W. E., & Shay, J. W. (2001) · Trends in Biotechnology · doi:10.1016/s0167-7799(00)01541-9 · Cited by 171
Small nucleolar RNAs: versatile trans-acting molecules of ancient evolutionary origin.
Terns, M. P., & Terns, R. M. (2002) · Europe PMC (PubMed Central) · Cited by 199
Antisense telomerase treatment: induction of two distinct pathways, apoptosis and differentiation
Kondo, S., Tanaka, Y., Kondo, Y., Hitomi, M., Barnett, G. H., Ishizaka, Y., Liu, J., Haqqi, T., Nishiyama, A., Villeponteau, B., et al. (1998) · The FASEB Journal · doi:10.1096/fasebj.12.10.801 · Cited by 170
“Since the same antisense vector against human telomerase RNA (17) was used in this study, it is expected that the telomere length of U251-MG cells tested by us was shortened by inhibition of telomerase function.”
BackgroundMethodInfluentialSelf-citationRefining the telomere-telomerase hypothesis of aging and cancer
Holt, S. E., Shay, J. W., & Wright, W. E. (1996) · Nature Biotechnology · doi:10.1038/nbt0796-836 · Cited by 167
Human Telomerase Inhibition by Regioisomeric Disubstituted Amidoanthracene-9,10-diones
Perry, P. J., Reszka, A. P., Wood, A. A., Read, M. A., Gowan, S. M., Dosanjh, H. S., Trent, J. O., Jenkins, T. C., Kelland, L. R., & Neidle, S. (1998) · Journal of Medicinal Chemistry · doi:10.1021/jm981067o · Cited by 165
Telomeres, telomerase and cancer: an up-date
Dhaene, K., Van Marck, E., & Parwaresch, R. (2000) · Virchows Archiv · doi:10.1007/s004280000189 · Cited by 165
“Using RT-PCR or Northern-blot assays, hTERC was found to be present in mortal primary cells and in a variety of normal human tissues that lacked enzyme activity [3, 23].”
Hiyama, E., Hiyama, K., Yokoyama, T., & Shay, J. W. (2001) · Neoplasia · doi:10.1038/sj.neo.7900134 · Cited by 162
Wang, W.-J., Li, J.-J., Rui, K., Gai, P.-P., Zhang, J.-R., & Zhu, J.-J. (2015) · Analytical Chemistry · doi:10.1021/ac504652e · Cited by 165
RNA–protein interaction mapping via MS2- or Cas13-based APEX targeting
Han, S., Zhao, B. S., Myers, S. A., Carr, S. A., He, C., & Ting, A. Y. (2020) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.2006617117 · Cited by 164
“While hTR’s interaction with the telomerase complex has been extensively characterized (28), hTR is present in stoichiometric excess over telomerase in cancer cells (29) and is broadly expressed in tissues lacking telomerase protein (30).”
BackgroundHuman telomerase contains two cooperating telomerase RNA molecules
Wenz, C. (2001) · The EMBO Journal · doi:10.1093/emboj/20.13.3526 · Cited by 163
Detection of Quadruplex DNA Structures in Human Telomeres by a Fluorescent Carbazole Derivative
Chang, C.-C., Kuo, I.-C., Ling, I.-F., Chen, C.-T., Chen, H.-C., Lou, P.-J., Lin, J.-J., & Chang, T.-C. (2004) · Analytical Chemistry · doi:10.1021/ac049510s · Cited by 160
Accelerated Telomere Shortening in Fibroblasts After Extended Periods of Confluency
Sitte, N. (1998) · Free Radical Biology and Medicine · doi:10.1016/s0891-5849(97)00363-8 · Cited by 164
A critical stem-loop structure in the CR4-CR5 domain of mammalian telomerase RNA
Chen, J.-L. (2002) · Nucleic Acids Research · doi:10.1093/nar/30.2.592 · Cited by 162
Telomerase in the early detection of cancer.
Shay, J. W., & Gazdar, A. F. (1997) · Journal of Clinical Pathology · doi:10.1136/jcp.50.2.106 · Cited by 160
Small nucleolar RNAs in cancer
Mannoor, K., Liao, J., & Jiang, F. (2012) · Biochimica et Biophysica Acta (BBA) - Reviews on Cancer · doi:10.1016/j.bbcan.2012.03.005 · Cited by 157
Human diseases of telomerase dysfunction: insights into tissue aging
Garcia, C. K., Wright, W. E., & Shay, J. W. (2007) · Nucleic Acids Research · doi:10.1093/nar/gkm644 · Cited by 157
“Telomerase is a multimeric ribonucleoprotein complex consisting of at least a functional RNA (hTR) that contains the template region complementary to the telomeric sequence (1) and a reverse transcriptase protein component (hTERT) that catalyzes the addition of telomeric repeats to the ends of chromosomes (2,3).”
BackgroundRevisiting Telomere Shortening in Cancer
Okamoto, K., & Seimiya, H. (2019) · Cells · doi:10.3390/cells8020107 · Cited by 152
“In human normal somatic cells, TERC is constitutively expressed, whereas TERT expression is epigenetically silenced [6,7].”
BackgroundLi, S., Crothers, J., Haqq, C. M., & Blackburn, E. H. (2005) · Journal of Biological Chemistry · doi:10.1074/jbc.m502782200 · Cited by 158
Characterization and developmental patterns of telomerase expression in plants
Fitzgerald, M. S., McKnight, T. D., & Shippen, D. E. (1996) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.93.25.14422 · Cited by 162
The Role of Telomere Biology in Cancer
Xu, L., Li, S., & Stohr, B. A. (2013) · Annual Review of Pathology: Mechanisms of Disease · doi:10.1146/annurev-pathol-020712-164030 · Cited by 160
Inhibition of telomerase activity by HDV ribozyme in cancers
Lu, Y., Gu, J., Jin, D., Gao, Y., & Yuan, M. (2011) · Journal of Experimental & Clinical Cancer Research · doi:10.1186/1756-9966-30-1 · Cited by 161
“Human telomerase RNA (hTR) is associated with the activity of telomerase, immortalized cancer cells retain the highest level of hTR [4,5].”
Background1,4- and 2,6-Disubstituted Amidoanthracene-9,10-dione Derivatives as Inhibitors of Human Telomerase
Perry, P. J., Gowan, S. M., Reszka, A. P., Polucci, P., Jenkins, T. C., Kèlland, L. R., & Neidle, S. (1998) · Journal of Medicinal Chemistry · doi:10.1021/jm9801105 · Cited by 171
Selective cytotoxicity and telomere damage in leukemia cells using the telomerase inhibitor BIBR1532
Eldaly, H., Kull, M., Zimmermann, S., Pantić, M., Waller, C. F., & Martens, U. M. (2004) · Blood · doi:10.1182/blood-2003-12-4322 · Cited by 171
Wu, Z.-Q., Guo, Q.-L., You, Q.-D., Zhao, L., & Gu, H.-Y. (2004) · Biological and Pharmaceutical Bulletin · doi:10.1248/bpb.27.1769 · Cited by 158
Experimental elongation of telomeres extends the lifespan of immortal x normal cell hybrids.
Wright, W. E., Brasiskyte, D., Piatyszek, M. A., & Shay, J. W. (1996) · The EMBO Journal · doi:10.1002/j.1460-2075.1996.tb00519.x · Cited by 158
Prescott, J., & Blackburn, E. H. (1997) · Genes & Development · doi:10.1101/gad.11.4.528 · Cited by 154
Transcription Regulation of the Human Telomerase Reverse Transcriptase (hTERT) Gene
Ramlee, M. K., Wang, J., Toh, W. H., & Li, S. (2016) · Genes · doi:10.3390/genes7080050 · Cited by 175
“Human core telomerase consists of at least two essential subunits, the protein subunit, human Telomerase Reverse Transcriptase (hTERT), and the RNA subunit, human Telomerase RNA (hTR) [5,6].”
BackgroundHaendeler, J., Hoffmann, J., Rahman, S., Zeiher, A. M., & Dimmeler, S. (2003) · FEBS Letters · doi:10.1016/s0014-5793(03)00058-9 · Cited by 154
Regulation of Telomere Length and Telomerase in T and B Cells
Weng, N., Hathcock, K. S., & Hodes, R. J. (1998) · Immunity · doi:10.1016/s1074-7613(00)80597-x · Cited by 171
Severe growth defect in mouse cells lacking the telomerase RNA component
Niida, H., Matsumoto, T., Satoh, H., Shiwa, M., Tokutake, Y., Furuichi, Y., & Shinkai, Y. (1998) · Nature Genetics · doi:10.1038/580 · Cited by 156
Frequent amplification of the telomerase reverse transcriptase gene in human tumors.
Zhang, A., Zheng, C., Lindvall, C. J., Hou, M., Ekedahl, J., Lewensohn, R., Yan, Z.-Q., Yang, X., Henriksson, M., Blennow, E., et al. (2000) · PubMed · Cited by 186
Jia, N., Lian, Q., Shen, H., Wang, C., Li, X., & Yang, Z. (2007) · Nano Letters · doi:10.1021/nl071114c · Cited by 156
Broccoli, D., Godley, L. A., Donehower, L. A., Varmus, H. E., & De Lange, T. (1996) · Molecular and Cellular Biology · doi:10.1128/mcb.16.7.3765 · Cited by 157
“When telomerase is absent, chromosomes show progressive terminal sequence loss with cell divisions (23, 46, 57), probably reflecting the fact that the chromosomal replication machinery cannot duplicate DNA ends (61).”
BackgroundFunk, W. D., Wang, C. K., Shelton, D. N., Harley, C. B., Pagon, G. D., & Hoeffler, W. K. (2000) · Experimental Cell Research · doi:10.1006/excr.2000.4945 · Cited by 162
Self-citationHartmann, N., Reichwald, K., Lechel, A., Graf, M., Kirschner, J., Dorn, A., Tozzini, E. T., Wellner, J., Platzer, M., Rudolph, K. L., et al. (2009) · Mechanisms of Ageing and Development · doi:10.1016/j.mad.2009.01.003 · Cited by 173
“In humans, expression of the TERT gene is primarily detectable in highly proliferating cells and correlates with detectable levels of telomerase activity, while TERC is constitutively expressed (Feng et al., 1995; Avilion et al., 1996; Nakamura et al., 1997).”
BackgroundWu, L. J., Wang, J., Feng, L., Ren, J., Wei, W., & Qu, X. (2012) · Advanced Materials · doi:10.1002/adma.201200412 · Cited by 155
Transcriptional Regulation of Telomerase Reverse Transcriptase (TERT) by MYC
Khattar, E., & Tergaonkar, V. (2017) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2017.00001 · Cited by 158
“Telomerase activity is detected in highly proliferating cells like stem cells, immune cells and germ cells (Feng et al., 1995; Avilion et al., 1996; Nakamura et al., 1997).”
BackgroundLong telomeres and cancer risk: the price of cellular immortality
McNally, E. J., Luncsford, P. J., & Armanios, M. Y. (2019) · Journal of Clinical Investigation · doi:10.1172/jci120851 · Cited by 167
Mittal, A., Pate, M., Wylie, R., Tollefsbol, T., & Katiyar, S. (2004) · International Journal of Oncology · doi:10.3892/ijo.24.3.703 · Cited by 154
In situ analysis of changes in telomere size during replicative aging and cell transformation.
Henderson, S. C., Allsopp, R., Spector, D. L., Wang, S. S., & Harley, C. (1996) · The Journal of Cell Biology · doi:10.1083/jcb.134.1.1 · Cited by 162
“The RNA component of telomerase contains a short motif which corresponds to the telomeric DNA sequence and which provides a template for the addition of telomeric DNA onto the 3' terminus of chromosomal ends (Greider and Blackburn, 1989; Feng et al., 1995).”
BackgroundSelf-citationPatry, C., Bouchard, L., Labrecque, P., Gendron, D., Lemieux, B., Toutant, J., Lapointe, E., Wellinger, R. J., & Chabot, B. (2003) · PubMed · Cited by 173
Telomere loss in cells treated with cisplatin
Ishibashi, T., & Lippard, S. J. (1998) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.95.8.4219 · Cited by 168
Tahara, H., Yasui, W., Tahara, E., Fujimoto, J., Ito, K., Tamai, K., Nakayama, J., Ishikawa, F., Tahara, E., & Ide, T. (1999) · Oncogene · doi:10.1038/sj.onc.1202458 · Cited by 167
“Telomerase components such as hTERC (human telomerase RNA component also known as hTR (Avilion et al., 1996; Feng et al., 1995)) and hTEP1 (telomerase protein 1 also known as TLP1/TP1 (Harrington et al., 1997a; Nakayama et al., 1997)) are expressed constitutively in both normal…”
BackgroundExpression profile of the putative catalytic subunit of the telomerase gene.
Ramakrishnan, S., Eppenberger, U., Mueller, H., Shinkai, Y., & Narayanan, R. (1998) · PubMed · Cited by 164
Est1 has the properties of a single-stranded telomere end-binding protein.
Virta-Pearlman, V, Morris, D. K., & Lundblad, V (1996) · Genes & Development · doi:10.1101/gad.10.24.3094 · Cited by 150
Functionally interacting telomerase RNAs in the yeast telomerase complex
Prescott, J., & Blackburn, E. H. (1997) · Genes & Development · doi:10.1101/gad.11.21.2790 · Cited by 150
“Mammalian telomerases contain an ∼450-nucleotide RNA and at least one protein, an ∼250-kD protein subunit with homology to Tetrahymena p80 (Blasco et al. 1995; Feng et al. 1995; Harrington et al. 1997; Nakayama et al. 1997).”
BackgroundTRF1 promotes parallel pairing of telomeric tracts in vitro
Griffith, J., Bianchi, A., & de Lange, T. (1998) · Journal of Molecular Biology · doi:10.1006/jmbi.1998.1686 · Cited by 148
Human Telomerase RNA Processing and Quality Control
Tseng, C.-K., Wang, H.-F., Burns, A. M., Schroeder, M. R., Gaspari, M., & Baumann, P. (2015) · Cell Reports · doi:10.1016/j.celrep.2015.10.075 · Cited by 148
“Longer forms have been reported (Feng et al., 1995; Theimer et al., 2007), but how primary transcripts are processed had remained elusive thus far (Figure S1).”
BackgroundBcl-2 Modulates Telomerase Activity
Mandal, M., & Kumar, R. (1997) · Journal of Biological Chemistry · doi:10.1074/jbc.272.22.14183 · Cited by 156
Telomere shortening in mTR−/− embryos is associated with failure to close the neural tube
Herrera, E., Samper, E., & Blasco, M. A. (1999) · The EMBO Journal · doi:10.1093/emboj/18.5.1172 · Cited by 147
Is telomerase a viable target in cancer?
Buseman, C. M., Wright, W. E., & Shay, J. W. (2012) · Mutation Research - Fundamental and Molecular Mechanisms of Mutagenesis · doi:10.1016/j.mrfmmm.2011.07.006 · Cited by 148
“The human telomerase holoenzyme core components are a catalytic reverse transcriptase called hTERT (human telomerase reverse transcriptase) [35,36], and an associated template RNA called hTR or hTERC (human Telomerase RNA) [36–39].”
Inventory of telomerase components in human cells reveals multiple subpopulations of hTR and hTERT
Xi, L., & Cech, T. R. (2014) · Nucleic Acids Research · doi:10.1093/nar/gku560 · Cited by 145
Telomeres, telomerase, and myc. An update
Cerni, C. (2000) · Mutation Research/Reviews in Mutation Research · doi:10.1016/s1383-5742(99)00091-5 · Cited by 160
Telomerase activation, cellular immortalization and cancer
Hahn, W. C., & Meyerson, M. (2001) · Annals of Medicine · doi:10.3109/07853890109002067 · Cited by 142
Telomeres and Telomerase in Aging, Regeneration and Cancer
Djojosubroto, M. W., Choi, Y. S., Lee, H.-W., & Rudolph, K. L. (2003) · Molecules and Cells · doi:10.1016/s1016-8478(23)13723-x · Cited by 147
Functional Multimerization of the Human Telomerase Reverse Transcriptase
Beattie, T. L., Zhou, W., Robinson, M. O., & Harrington, L. (2001) · Molecular and Cellular Biology · doi:10.1128/mcb.21.18.6151-6160.2001 · Cited by 146
“The RNA was subsequently electrophoresed, transferred to membrane, and probed for hTER as previously described (5, 17 ).”
MethodImpaired germinal center reaction in mice with short telomeres
Herrera, E., Martínez‐A, C., & Blasco, M. A. (2000) · The EMBO Journal · doi:10.1093/emboj/19.3.472 · Cited by 144
Inhibition of human telomerase by 2′- O -methyl-RNA
Pitts, A. E., & Corey, D. R. (1998) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.95.20.11549 · Cited by 144
Therapeutic Targeting of Telomerase
Jäger, K., & Walter, M. (2016) · Genes · doi:10.3390/genes7070039 · Cited by 139
“Antisense oligonucleotides and chemically-modified nucleic acids have been shown to inhibit telomerase and to induce telomere shortening [131–135] associated with subsequent onset of senescence and/or apoptosis in cell cultures [134–137].”
BackgroundTelomerase in human development and cancer
Shay, J. W. (1997) · Journal of Cellular Physiology · doi:10.1002/(sici)1097-4652(199711)173:2<266::aid-jcp33>3.0.co;2-b · Cited by 141
Telomere length regulation during postnatal development and ageing in Mus spretus
Coviello-McLaughlin, G. (1997) · Nucleic Acids Research · doi:10.1093/nar/25.15.3051 · Cited by 141
Role of Telomeres and Telomerase in the Pathogenesis of Human Cancer
Hahn, W. C. (2003) · Journal of Clinical Oncology · doi:10.1200/jco.2003.06.018 · Cited by 143
“hTERC, the RNA subunit, provides the template for the telomere synthesis reaction and is ubiquitously expressed in mammalian cells.(30) In addition, hTERC is a member of a class of small nucleolar RNA molecules termed box H/ACA RNAs.”
BackgroundEstrogen reduces endothelial progenitor cell senescence through augmentation of telomerase activity
Imanishi, T., Hano, T., & Nishio, I. (2005) · Journal of Hypertension · doi:10.1097/01.hjh.0000176788.12376.20 · Cited by 144
CTCF binds the proximal exonic region of hTERT and inhibits its transcription
Renaud, S. (2005) · Nucleic Acids Research · doi:10.1093/nar/gki989 · Cited by 138
Inhibition of telomerase activity by cisplatin in human testicular cancer cells
Burger, A. M., Double, J. A., & Newell, D. R. (1997) · European Journal of Cancer · doi:10.1016/s0959-8049(96)00521-7 · Cited by 141
Involvement of hTERT in apoptosis induced by interference with Bcl-2 expression and function
Bufalo, D. D., Rizzo, A., Trisciuoglio, D., Cardinali, G., Torrisi, M. R., Zangemeister‐Wittke, U., Zupi, G., & Biroccio, A. (2005) · Cell Death and Differentiation · doi:10.1038/sj.cdd.4401670 · Cited by 149
The roles of telomeres and telomerase in cell life span
Counter, C. M. (1996) · Mutation Research/Reviews in Genetic Toxicology · doi:10.1016/s0165-1110(96)90006-8 · Cited by 154
Normal Human Telomeres Are Not Late Replicating
Wright, W. E., Tesmer, V. M., Liao, M., & Shay, J. W. (1999) · Experimental Cell Research · doi:10.1006/excr.1999.4602 · Cited by 159
E2F-1 represses transcription of the human telomerase reverse transcriptase gene
Crowe, D. L. (2001) · Nucleic Acids Research · doi:10.1093/nar/29.13.2789 · Cited by 135
“Telomerase synthesizes telomeric DNA onto chromosome ends using its RNA component as template (10,11).”
MethodNiida, H., Shinkai, Y., Hande, M. P., Matsumoto, T., Takehara, S., Tachibana, M., Oshimura, M., Lansdorp, P. M., & Furuichi, Y. (2000) · Molecular and Cellular Biology · doi:10.1128/mcb.20.11.4115-4127.2000 · Cited by 138
“Cloning and expression of the mammalian telomerase RNA gene encoding the template for telomeric DNA synthesis and the gene encoding the catalytic reverse transcriptase subunit of the telomerase complex have shown that these two gene products are essential and sufficient to reconstitute telomerase activity (3, 13 , 21,…”
BackgroundA model for heterogeneous nuclear ribonucleoproteins in telomere and telomerase regulation
Ford, L. P., Wright, W. E., & Shay, J. W. (2002) · Oncogene · doi:10.1038/sj.onc.1205086 · Cited by 149
“…reverse transcriptase, called telomerase that is minimally composed of a functional `template' RNA and a catalytic protein that contains conserved reverse transcriptase motifs (Feng et al., 1995; Greider and Blackburn, 1989; Lingner et al., 1997b; Meyerson et al., 1997a; Nakamura et al., 1997).”
BackgroundIto, H., Kyo, S., Kanaya, T., Takakura, M., Inoue, M., & Namiki, M. (1998) · PubMed · Cited by 157
Ducray, C., Pommier, J., Martins, L., Boussin, F. D., & Sabatier, L. (1999) · Oncogene · doi:10.1038/sj.onc.1202797 · Cited by 149
“This suggested that telomerase activity was not regulated on its RNA component basis after immortalization as it has been previously described (Feng et al., 1995; Blasco et al., 1996).”
Telomere dysfunction, genome instability and cancer
Cheung, A. (2008) · Frontiers in Bioscience · doi:10.2741/2825 · Cited by 139
“Subsequently, the RNA component of telomerase, termed hTR, in human cells was cloned and sequenced (57).”
BackgroundIdentification of Two RNA-binding Proteins Associated with Human Telomerase RNA
Le, S., Sternglanz, R., & Greider, C. W. (2000) · Molecular Biology of the Cell · doi:10.1091/mbc.11.3.999 · Cited by 136
Self-citationTelomerase inhibition by peptide nucleic acids reverses `immortality' of transformed human cells
Shammas, M. A., Simmons, C. G., Corey, D. R., & Shmookler Reis, R. J. (1999) · Oncogene · doi:10.1038/sj.onc.1203069 · Cited by 135
“…appeared to enter crisis (see below), much as reported for HeLa cell clones stably transfected with a plasmid expressing antisense telomerase RNA (Feng et al., 1995), and for a human glioblastoma line stably transfected with the same anti-telomerase plasmid, although a subset of di erentiated…”
BackgroundA virus-encoded telomerase RNA promotes malignant T cell lymphomagenesis
Trapp, S., Parcells, M. S., Kamil, J. P., Schumacher, D., Tischer, B. K., Kumar, P. M., Nair, V., & Osterrieder, N. (2006) · The Journal of Experimental Medicine · doi:10.1084/jem.20052240 · Cited by 141
“Unlike TERT, whose expression correlates with telomerase activity, TR is constitutively expressed in somatic cells (8); however, generally, cancer cells have elevated levels of TR.”
BackgroundTelomeres and Telomerase: Implications for Cancer and Aging
Shay, J. W., & Wright, W. E. (2001) · Radiation Research · doi:10.1667/0033-7587(2001)155[0188:tatifc]2.0.co;2 · Cited by 134
p53-dependent Down-regulation of Telomerase Is Mediated by p21
Shats, I., Milyavsky, M., Tang, X., Stambolsky, P., Erez, N., Brosh, R., Kogan, I., Braunstein, I., Tzukerman, M., Ginsberg, D., et al. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.m402502200 · Cited by 133
Idiopathic Pulmonary Fibrosis: Update on Genetic Discoveries
Garcia, C. K. (2011) · Proceedings of the American Thoracic Society · doi:10.1513/pats.201008-056ms · Cited by 126
“Telomerase is a multimeric ribonucleoprotein enzyme that catalyzes the addition of repetitive DNA sequence to the telomeres, or specialized structures at the ends of chromosomes (16, 17).”
BackgroundTelomerase Recruitment Requires both TCAB1 and Cajal Bodies Independently
Stern, J. L., Zyner, K. G., Pickett, H. A., Cohen, S. B., & Bryan, T. M. (2012) · Molecular and Cellular Biology · doi:10.1128/mcb.00379-12 · Cited by 150
“The purified DNA (70 l) was added to 490 l of 0.46 M NaOH, heated to 95°C for 5 min, and cooled on ice before dot blotting on Hybond XL (GE Healthcare Life Sciences) according to the manufacturer’s protocol.”
BackgroundInfluentialLou, X., Zhuang, Y., Zuo, X., Jia, Y., Hong, Y., Min, X., Zhang, Z., Xu, X., Liu, N., Xia, F., et al. (2015) · Analytical Chemistry · doi:10.1021/acs.analchem.5b01099 · Cited by 134
Telomere DNA G-quadruplex folding within actively extending human telomerase
Jansson, L. I., Hentschel, J., Parks, J. W., Chang, T. R., Lu, C. C., Baral, R., Bagshaw, C. R., & Stone, M. D. (2019) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1814777116 · Cited by 138
“Telomerase is a ribonucleoprotein (RNP) complex that includes the long noncoding telomerase RNA (TR) and the catalytic telomerase reverse transcriptase (TERT) protein subunit (23, 24).”
BackgroundArmstrong, L., Lako, M., Lincoln, J., Cairns, P. M., & Hole, N. (2000) · Mechanisms of Development · doi:10.1016/s0925-4773(00)00423-8 · Cited by 151
“Telomeric DNA cannot be replicated by conventional DNA polymerases; this function is carried out by the specialized ribonucleoprotein complex telomerase, whose RNA moiety contains a template domain for the de novo addition of deoxynucleotides to the G-rich strand and thus allows the maintenance of telomere length (Fen…”
Komata, T., Kondo, Y., Kanzawa, T., Hirohata, S., Koga, S., Sumiyoshi, H., Srinivasula, S. M., Barna, B. P., Germano, I. M., Takakura, M., et al. (2001) · PubMed · Cited by 156
Palmer, L. D., Weng, N.-P., Levine, B. L., June, C. H., Lane, H. C., & Hodes, R. J. (1997) · The Journal of Experimental Medicine · doi:10.1084/jem.185.7.1381 · Cited by 129
“A ribonucleoprotein enzyme, telomerase, has the capacity to add hexanucleotide telomeric repeats to chromosomes, thus maintaining telomere length (9, 10).”
BackgroundLu, Y., Ou, T., Tan, J.-H., Hou, J.-Q., Shao, W.-Y., Peng, D., Sun, N., Wang, X.-D., Wu, W.-B., Bu, X., et al. (2008) · Journal of Medicinal Chemistry · doi:10.1021/jm800497p · Cited by 134
Getting to the end: telomerase access in yeast and humans
Vega, L. R., Mateyak, M. K., & Zakian, V. A. (2003) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm1256 · Cited by 144
Mechanisms of chromosome instability in cancers
Jefford, C. E., & Irminger‐Finger, I. (2006) · Critical Reviews in Oncology/Hematology · doi:10.1016/j.critrevonc.2006.02.005 · Cited by 157
Cairney, C. J., & Keith, W. N. (2007) · Biochimie · doi:10.1016/j.biochi.2007.07.025 · Cited by 140
Hormones and growth factors regulate telomerase activity in ageing and cancer
Bayne, S., & Liu, J. (2005) · Molecular and Cellular Endocrinology · doi:10.1016/j.mce.2005.05.009 · Cited by 132
Bechter, O. E., Eisterer, W., Pall, G., Hilbe, W., Kühr, T., & Thaler, J. (1998) · PubMed · Cited by 144
Selective inhibition of telomerase activity during terminal differentiation of immortal cell lines.
Bestilny, L. J., Brown, C. B., Miura, Y., Robertson, L. D., & Riabowol, K. T. (1996) · PubMed · Cited by 133
TER1, the RNA subunit of fission yeast telomerase
Leonardi, J., Box, J. A., Bunch, J. T., & Baumann, P. (2007) · Nature Structural & Molecular Biology · doi:10.1038/nsmb1343 · Cited by 141
Sirtuins in stress response: guardians of the genome
Bosch‐Presegué, L., & Vaquero, A. (2013) · Oncogene · doi:10.1038/onc.2013.344 · Cited by 136
Telomere Inhibition and Telomere Disruption as Processes for Drug Targeting
Rezler, E. M., Bearss, D. J., & Hurley, L. H. (2003) · The Annual Review of Pharmacology and Toxicology · doi:10.1146/annurev.pharmtox.43.100901.135733 · Cited by 132
Marrone, A., Stevens, D., Vulliamy, T., Dokal, I., & Mason, P. J. (2004) · Blood · doi:10.1182/blood-2004-05-1829 · Cited by 126
Low abundance of telomerase in yeast: Implications for telomerase haploinsufficiency
Mozdy, A. D., & Cech, T. R. (2006) · RNA · doi:10.1261/rna.134706 · Cited by 126
“The missing or limiting telomerase component in normal human somatic cells is probably TERT, because the telomerase RNA, hTR, is present in all cell types (Feng et al. 1995).”
Background
Metadata
- Authors
- Feng, J., Funk, W. D., Wang, S.-S., Weinrich, S. L., Avilion, A. A., Chiu, C.-P., Adams, R. R., Chang, E., Allsopp, R. C., Yu, J., Le, S., West, M. D., Harley, C. B., Andrews, Greider, C. W., & Villeponteau, B.
- Affiliations
- Geron (United States) (US)
- Cold Spring Harbor Laboratory (US)
- ORCID
- Venue
- Science
- Published
- 1995-09
- Volume
- 269
- Issue
- 5228
- Pages
- 1236-1241
- ISSN
- 0036-8075 (ISSN-L)
- 1095-9203
- OpenAlex
- W2026856852
- Cited by
- 2,227
- References
- 44
- Citations by year
- 2026: 10 · 2025: 23 · 2024: 20 · 2023: 36 · 2022: 35 · 2021: 33 · 2020: 44 · 2019: 52 · 2018: 55 · 2017: 44 · 2016: 74 · 2015: 54 · 2014: 47 · 2013: 62 · 2012: 61
- FWCI
- 54.67
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Science (publishedVersion)
- PubMed (publishedVersion)
- Funders
- National Institute on Aging (AG09383)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cell Biology › Telomeres, Telomerase, and Senescence
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Aging › Genetics, Aging, and Longevity in Model Organisms
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › DNA and Nucleic Acid Chemistry
- Keywords
- telomerase, hTR, telomeric repeats, antisense RNA, telomere shortening, HeLa cells
- MeSH terms
- Animals, Base Sequence, Cell Division, Cell Line, Cloning, Molecular, DNA Nucleotidylexotransferase, HeLa Cells, Humans, Molecular Sequence Data, RNA, Templates, Genetic, Transfection, Tumor Cells, Cultured, Polymerase Chain Reaction, Oligonucleotides, Antisense, Cell Death
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.